After COVID-19 Vaccine Setbacks, GSK Expands Vir Antibody Pact

Companies’ Respiratory Deal Aims Beyond Coronavirus

 
• By Alaric DeArment
  
3D_Coronavirus
GSK is expanding its pact with Vir after setbacks on COVID-19 vaccines. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip